These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 22687848)
21. Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma. McClanahan F; Hielscher T; Rieger M; Hensel M; Bentz M; Schmidt-Wolf I; Käbisch A; Salwender H; Dürk H; Staiger H; Mandel T; Neben K; Hillengass J; Leo E; Krämer A; Ho AD; Witzens-Harig M Am J Hematol; 2012 Oct; 87(10):E68-71. PubMed ID: 22847344 [No Abstract] [Full Text] [Related]
22. Progressive multifocal leukoencephalopathy during rituximab maintenance after rituximab and bendamustine treatment for relapsed follicular lymphoma. Lucijanic M; Jaksic O Ann Hematol; 2020 Sep; 99(9):2191-2192. PubMed ID: 32556456 [No Abstract] [Full Text] [Related]
23. A phase III trial of CHOP vs CHOP + rituximab vs CHOP + 1-131 tositumomab for newly diagnosed follicular non-Hodgkin lymphoma. Clin Adv Hematol Oncol; 2006 Jul; 4(7):536-8. PubMed ID: 17147240 [No Abstract] [Full Text] [Related]
24. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation. Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127 [TBL] [Abstract][Full Text] [Related]
25. The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Andresen S; Brandt J; Dietrich S; Memmer ML; Ho AD; Witzens-Harig M Leuk Lymphoma; 2012 Mar; 53(3):386-93. PubMed ID: 21864036 [TBL] [Abstract][Full Text] [Related]
26. Follicular lymphoma: 2012 update on diagnosis and management. Freedman A Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911 [TBL] [Abstract][Full Text] [Related]
27. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study. Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156 [TBL] [Abstract][Full Text] [Related]
28. [A case of follicular lymphoma with onset of chylothorax]. Hanaoka N; Nagao H; Murakami T; Chijiwa T; Suganuma T Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):31-5. PubMed ID: 17313024 [TBL] [Abstract][Full Text] [Related]
30. Lenalidomide in combination with R-CHOP (R2-CHOP) in patients with high burden follicular lymphoma: phase 2 study. Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):12; 14-5. PubMed ID: 24870876 [No Abstract] [Full Text] [Related]
31. Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Hayslip JW; Simpson KN Clin Lymphoma Myeloma; 2008 Jun; 8(3):166-70. PubMed ID: 18650180 [TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era. Procházka V; Papajík T; Faber E; Raida L; Kapitáňová Z; Langová K; Prouzová Z; Jarošová M; Indrák K Leuk Lymphoma; 2014 Jul; 55(7):1584-90. PubMed ID: 24180329 [TBL] [Abstract][Full Text] [Related]
33. FcγRIIA and FcγRIIIA polymorphisms do not influence survival and response to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy in patients with diffuse large B-cell lymphoma. Fabisiewicz A; Paszkiewicz-Kozik E; Osowiecki M; Walewski J; Siedlecki JA Leuk Lymphoma; 2011 Aug; 52(8):1604-6. PubMed ID: 21657954 [No Abstract] [Full Text] [Related]
34. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma. Chan TS; Khong PL; Kwong YL Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194 [No Abstract] [Full Text] [Related]
35. [Follicular lymphoma showing long-term false positive results by FDG-PET after rituximab-containing chemotherapy]. Miyazaki Y; Nawa Y; Kohashi S; Nakase K; Miyagawa M; Hara M Rinsho Ketsueki; 2012 Feb; 53(2):252-4. PubMed ID: 22450588 [TBL] [Abstract][Full Text] [Related]
37. Pediatric-Type Follicular Lymphoma in the Dura: A Case Report and Literature Review. Yamaguchi J; Kato S; Iwata E; Aoki K; Kabeya R; Natsume A; Wakabayashi T World Neurosurg; 2018 Jul; 115():176-180. PubMed ID: 29678710 [TBL] [Abstract][Full Text] [Related]
38. Diagnosis of a primary cardiac B-cell lymphoma. Menke J; Unterberg-Buchwald C; Schaefer IM; Kertesz A Am J Hematol; 2012 Apr; 87(4):426-7. PubMed ID: 21953722 [No Abstract] [Full Text] [Related]
39. Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under Gutsch J; Werthmann PG; Rosenwald A; Kienle GS Anticancer Res; 2018 Sep; 38(9):5363-5369. PubMed ID: 30194190 [TBL] [Abstract][Full Text] [Related]
40. Primary gastrointestinal follicular lymphoma with histological transformation. Hangai S; Nakamura F; Kamikubo Y; Ichikawa M; Suzuki H; Yoshida S; Yamada A; Takazawa Y; Fukayama M; Koike K; Kurokawa M Ann Hematol; 2013 Jul; 92(7):993-4. PubMed ID: 23271213 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]